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Attention-deficit hyperactivity disorder (ADHD) in adults is associated with impaired sleep, and
it has been postulated that this impairment may contribute to the psychopathology of this
common condition. One key driver of sleep/wake cycles is the circadian system, which at the
molecular level consists of a series of transcriptional feedback loops of clock genes, which in
turn produce endocrine, physiological and behavioural outputs with a near 24h periodicity.
We set out to examine circadian rhythms at the behavioural, endocrine and molecular levels
in ADHD. Adults with ADHD as well as age- and sex-matched controls were recruited.
Circadian rhythms were measured by means of actigraphy for the determination of gross
motor patterns, by self-sampling of oral mucosa for assessment of rhythmic expression of the
clock genes BMAL1 and PER2, and by estimation of salivary cortisol and melatonin levels.
Actigraphic analysis revealed significant diurnal and nocturnal hyperactivity in the ADHD
group, as well as a significant shorter period of best fit for the locomotor circadian rhythm in
ADHD. BMAL1 and PER2 showed circadian rhythmicity in controls with this being lost in the
ADHD group. Cortisol rhythms were significantly phase delayed in the ADHD group. These
findings indicate that adult ADHD is accompanied by significant changes in the circadian
system, which in turn may lead to decreased sleep duration and quality in the condition.
Further, modulation of circadian rhythms may represent a novel therapeutic avenue in the
management of ADHD.
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Introduction
Attention-deficit hyperactivity disorder (ADHD) is a
psychiatric condition that can affect both children and
adults, with an estimated prevalence of 3.4% in
adults.1 The disorder is characterised by behavioural
and attention difficulties, which can lead to secondary
problems such as drug addiction and delinquency in
adults.2 Sleep deficits are a prominent characteristic of
the disorder, with up to 83% of adult with ADHD
reporting problems with sleep.3 Actigraphy and poly-
somnography studies of sleep disturbance in ADHD
have demonstrated significant association of sleep
disturbance with both childhood and adult ADHD,
including delayed sleep onset and difficulties in
awakening, increased nocturnal activity, reduced
sleep efficiency and reduced percentage of Rapid
Eye Movement (REM) sleep.4–7 Furthermore, the core
symptoms of ADHD, inattention, impulsivity and
restlessness, are known characteristics of sleep depri-
vation.8 Chronic sleep-onset insomnia has also been
shown to be associated with childhood and adult
ADHD.9,10 ADHD is also associated with changes in
diurnal preference towards greater eveningness.4
The circadian clock is responsible for the genera-
tion of rhythms of behaviour and physiology on a near
24 period base, and has a key role in determining the
rhythm of the sleep/wake cycle.11 The master clock is
in the suprachiasmatic nuclei (SCN) of the hypotha-
lamus and it is entrained to the 24h day via retinal
photic input with further semiautonomous oscillators
present throughout the brain and periphery.12 SCN
output is responsible for driving circadian rhythms
in a number of hormones, including melatonin and
cortisol. Abnormal rhythms of melatonin secretion
has been associated with childhood and adult
ADHD.9,10 Cortisol circadian profiles have been
reported to be either unaltered in ADHD12 or altered
in association primarily with the hyperactive subtype
of ADHD.13,14 The molecular basis of such circadian
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rhythm generation consists of positive and negative
transcriptional/translational feedback loops of ‘clock’
genes and their protein products, and single-nucleo-
tide polymorphism in clock genes have been asso-
ciated with ADHD.15–17 Given these indications that
the circadian clock may be compromised in ADHD,
we have examined for the first time circadian
rhythmicity at the molecular, endocrine and behav-
ioural levels in adult ADHD.
Materials and methods
Subjects and ethics
Adult ADHD patients were recruited from the Adult
ADHD clinic at Cefn Coed Hospital, Swansea, Wales,
(n=13) and age- and gender-matched healthy controls
(n=19) were recruited from the university staff,
hospital staff and a student population. Each partici-
pant was assessed by structured clinical interview
according to the international diagnostic criteria
(DSM-IV SCID-RV), in addition to ADHD question-
naires and psychometric tests (WHO’s Adult ADHD
Self Report Scale), Conners scales (CAARS-Self-
Report Long Version and CAARS-Observer Long
Version) and the Wender–Utah Rating Scale for
retrospective information on childhood ADH (group
scores in Supplementary Table 1). Information regard-
ing habitual sleep habits (bed time, time to fall asleep,
wake time and sleep duration), alcohol and substance
use was also gathered. Only control subjects who did
not show evidence of suffering from a current
psychiatric or sleep disorder were included in the
study. As ADHD in adults is associated with
high levels of psychiatric comorbidities, subjects
with current or lifetime mild comorbid conditions
were included to allow for a representative sample.
Participants with histories of severe psychiatric
illness were excluded, as were those who work night
shifts. Details of the included participants can
be found in Table 1. Chronotype was assessed by
Horne–Oestberg Morning–Eveningness questionnaire.
Informed consent was obtained from all participants,
and the study was approved by the Local Research
Ethics Committee for the NHS in Swansea.
Actigraphy
Subjects wore an ActiWatch Light (Cambridge Neuro-
tech, Cambridge, UK) on their nondominant wrist for
at least 7 days, the last day of which was when
mucosal/saliva samples were collected. Data were
collected in 1-min epochs. Measures of light exposure
were also collected via the actiwatches. Data analysis
excluded the first and last days of data collection.
Analysis of actigraphic data was via nonparametric
circadian rhythm analysis for at least 5 consecutive
days18 using the Actiwatch Sleep and Circadian
Rhythm Analysis Software (version 5.54, Cambridge
Neurotech). Objective measures of sleep parameters
(for example, sleep onset, sleep duration, sleep
efficiency and wake time) were also calculated from
the actigraphic data. Circadian period from acti-
graphic data was calculated via w2 periodograms for
data of at least 5 consecutive days. Details of the
nonparametric measures of circadian rhythms used
and what these represent can be found in the
Supplementary Materials and methods.
Clock gene analysis
Buccal samples were collected every 4h over a 24h
period using foam-tipped swab, and the material was
stored on FTA cards (Whatman International, Kent,
UK). RNAwas extracted using the Magmax viral RNA
isolation kit (Ambion, Warrington, UK). The quality
and quantity of total RNA isolated was confirmed
using the Experion automated electrophoresis system
(Bio-Rad, Hertfordshire, UK). There was no evidence
of variations of RNA quality according to time of
sampling. One-step quantitative real-time PCR
was performed using the Light Cycler 3.5 (Roche
Diagnostics, Mannheim, Germany) with SYBR-Green
I dye amplimer detection. Details of primers used and
PCR protocol are in the supplementary Materials and
methods. Normalisation was to glyceraldehyde-3-
phosphate dehydrogenase.19 Subjects were reminded
by short message service text message to take their
samples at the specified time, and post-hoc analysis
of the actigraphic activity record was used to confirm
the presence of an activity bout for at the nocturnal
sampling time points. Subjects collected samples first
during the day and then the night, so as that disturbed
sleep caused by sampling would not impact on
daytime values of gene expression.
Melatonin and cortisol analysis
Saliva samples were collected every 4 h over a 24h
period (at the same time periods as buccal sampling),
by chewing on a cotton swab (Bu¨hlmann Labora-
tories, Scho¨nebuch, Switzerland) and subsequently
stored at 20 1C before analysis. Subjects were asked
to collect nighttime samples under dim illumination.
Both the levels of salivary cortisol and melatonin
were assayed by ELISA (IBL International, Hamburg,
Germany).
Table 1 Characteristics of the study participants
Controls
(n=19)
ADHD
(n=13)
Age in years, mean±s.d. 32.3±13.3 31.3±11.7
Male 12 (63.1%) 8 (61.5%)
Current depression 0 (0%) 1 (7.7%)
Previous depression 1 (5.3%) 7 (53.8%)
Current anxiety disorder 0 (0%) 4 (30.7%)
No current comorbidities 19 (100%) 7 (53.8%)
Stimulant medication 0 (0%) 3 (23.1%)
Atomoxetine 0 (0%) 1 (7.7%)
Alcohol use >20 units per week 2 (10.5%) 1 (7.7%)
Habitual time to fall asleep >1h 0 (0%) 7 (53.8%)
Abbreviation: ADHD, attention-deficit hyperactivity disorder.
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Statistical analysis
Group-wise comparisons were conducted by Mann–
Whitney U tests or t-tests. Clock gene expression and
hormone data were fitted by the method of single
cosinor analysis to determine whether significant
circadian rhythms were present (Chronolab software,
Universidad de Vigo, Vigo, Spain).20 Briefly, this
entails fitting data via least squares regression to a
cosine curve with a 24h period. Cosinor analysis
produces measures of the rhythm peak-to-trough
amplitude (the fit was deemed significant if the
95% confidence interval for the fitted amplitude did
not include zero), the acrophase (time of the peak of
the rhythm) and the MESOR (the middle value of the
cosine wave). The regression fitting also produces an
R-squared statistic, which is then used to compute the
percentage of variance in an individuals time-series
data that is accounted for by the fitted 24-h curve. For
between-group comparisons of population choro-
metrics derived by this method, we used the Bingham
test,21 which compares the amplitude, MESOR, acro-
phase and amplitude/acrophase pair between groups.
Clock gene and hormone data are presented as
standardised Z-scores, to allow for the direct inter-
variable comparison of amplitudes between genes and
hormones measured in different units.22 The hormone
data were Z-scored from raw data, the clock gene data
were Z-scored from glyceraldehyde-3-phosphate de-
hydrogenase-normalised data. Data were also exam-
ined by the above methods before Z-scoring, with no
meaningful differences observed between the two
methods. Correlations between the DSM ADHD index
score and chronometric parameters were by the
Pearson’s product moment correlation.
Results
Actigraphy and diurnal preference
Analysis of actigraphic parameters is shown in
Table 1. The amount of activity in the least active
5h, L5, is significantly increased in the ADHD group,
as is the amount of activity in the most active 10h
period, M10, and this in turn leads to an increase in
the rhythm amplitude in the ADHD group (also
Supplementary Figure 1). Analysis of the period
shows that the ADHD group displayed significantly
shorter period than the controls (Table 1). There was
a significant increase in the average illumination in
the 6h between midnight and 0600 hours in ADHD
subjects compared with controls (Supplementary
Table 2). Morning–Eveningness questionnaire data
showed that the ADHD subjects scored significantly
higher than controls, indicating a shift to eveningness
(Table 1). There were significant inverse correlations
between the DSM index ADHD scores and the
Morning–Eveningness questionnaire and the acti-
graphic period (r=0.619 and 0.534, respectively,
both P<0.005). Objective measures of sleep indicate
differences in the amount of sleep and sleep effi-
ciency in the ADHD group compared with the
controls (Supplementary Table 3). Self-reported sleep
parameters indicate that 53% of the ADHD group
habitually took longer than 1h to fall asleep after
bedtime, while no controls reported this (Tables 1
and 2), suggesting the presence of sleep-onset
insomnia in a significant portion of the ADHD group.
Clock gene and hormone rhythms
BMAL1 exhibited rhythmic expression in the control
group, but not the ADHD group (Figures 1a and b).
The amplitude and amplitude/acrophase relation-
ship was found to be significantly different between
the control and ADHD groups (Figures 1b and c).
Rhythmic circadian expression of PER2 was found
in the control group, but the ADHD group did not
display a significant circadian rhythm in PER2
(Figure 1d), although between-groups comparisons
of chronometrics did not reveal any significant
differences (Figure 1f). Melatonin was strongly rhyth-
mic in the control group and the ADHD group
displayed a rhythm that appeared to be broadly
similar, but with a dampened amplitude that meant
the rhythm was not significant (Figures 2a and b).
Between-groups comparisons did not reveal signifi-
cant differences in any chronometrics (Figure 2c). For
salivary cortisol, the control group showed a robust
circadian rhythm with a peak in expressionB1h after
waking (Figures 2d and e). The ADHD group also
showed rhythmic cortisol, although the peak of
secretion was phase delayed relative to wake time
and occurred B3h after waking. This difference in
acrophase was found to be significant as was
the amplitude/acrophase relationship (Figure 2f).
When chronometrics from individual profiles were
Table 2 Actigraphic and diurnal preference measures in
control and ADHD groups
Controls
(n=19)
ADHD
(n=13)
Interdaily stability 0.579±0.03 0.546±0.03 (NS)
Intradaily
variability
0.785±0.05 0.707±0.05 (NS)
M10 19620±1156 25302±1430 (P<0.001)
M10 o (h) 9.52±0.32 10.8±1.01 (NS)
L5 841±98 1647±295 (P<0.001)
L5 o (h) 2.2±1.1 4.45±1.6 (NS)
Amplitude 18785±1156 23696±1273 (P<0.001)
Relative
amplitude
0.904±0.015 0.879±0.015 (NS.)
Period (h) 23.95±0.07 23.76±0.14 (P<0.001)
Acrophase (h) 14.62±0.29 14.83±0.66 (NS.)
Wake time (h) 7.96±0.27 8.61±0.47 (NS.)
MEQ score 52.6±1.4 41.5±2.9 (P<0.001)
Abbreviations: ADHD, attention deficit/hyperactivity dis-
order; MEQ, Morning–Eveningness Questionnaire; M10,
activity counts in the 10 most active hours; M10o, time of
onset of the 10 most active hours; L5, activity counts in the
5 least active hours; L5 o, time of onset of the least active
5 hours; NS=not significant.
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examined across the control group it was found that,
in agreement with the population profiles, there were
significant differences in the amplitude of the BMAL1
rhythms between the control and ADHD groups, as
well as a significant difference in the acrophases of
the two groups for the cortisol rhythm (Supplementary
Figure 2). We examined correlations between the
DSMIV-index ADHD score in participants in the control
and ADHD groups: in the control group we only found
a significant correlation between PER2 acrophase and
ADHD scores, while in the ADHD group we found
strong inverse correlations between the ADHD index
score and a number of chronometrics (Figure 3). We
also report significant correlations between actigraphic
measures of circadian behaviour and clock gene
chronometrics (Supplementary Figure 3).
Discussion
Actigraphy and diurnal preference
Actigraphic measures demonstrate hyperactivity of
the ADHD patients across the circadian cycle in the
current study, while Boonstra et al.7 report increases
in M10 (but not L5) in adult ADHD and no significant
differences in IS, IV or RA, similar to the present
results. We also report significant shortening of the
activity rhythm period in the ADHD group, one
possible explanation for which is altered entrainment
to external Zeitgebers in ADHD, as has been postu-
lated for the phase delay of the dim-light melatonin
onset.10 In our data set, there is a strong positive
correlation between the ADHD clinical score and
period length in the ADHD group, suggesting that the
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Figure 1 Circadian rhythms in BMAL1 and PER2 expression in oral mucosa in control and ADHD groups. (a) Chronograms
for the expression of BMAL1 in the oral mucosa of controls and the ADHD group. The fitted dark line represents the cosine
wave of best fit with a 24h period. The horizontal line represents the MESOR. (b) Polar plot illustrating the phase/amplitude
relationship for BMAL1 expression in the oral mucosa of controls (black ellipse) and ADHD subjects (hatched ellipse). Length
of the dotted white vector indicates amplitude of circadian rhythm and the orientation of this vector represents the acrophase
for the control group. Ninety-five percent confidence interval for the combined amplitude and acrophase are represented by
elliptical areas around the vector tips, indicated by lightly dashed line. Note that the error ellipse for the ADHD group covers
the zero point of amplitude, indicating a nonsignificant circadian fit for the observed data, while the error ellipse of the
control group does not overlap the zero point, indicating a significant cosinor fit. (c) Chronometrics for circadian BMAL1
expression in the control and ADHD groups. % Rhythm refers to the percentage of variance in the population data that is
explained by regression with the 24-h cosine wave of best fit. AMP is the amplitude of the rhythm, CI AMP is the 95%
confidence interval for the amplitude, Acro. is the time of the peak of the rhythm, CI Acro. is the 95% confidence interval for
the amplitude. * indicates P<0.05 by Bingham test between groups. (d) Chronograms illustrating the rhythmic expression of
PER2 in the oral mucosa of controls and the ADHD group. The fitted dark line represents the cosine wave of best fit with a
24h period. The horizontal line represents the MESOR. (e) Polar plot illustrating the phase/amplitude relationship for PER2
expression in the oral mucosa of controls (black ellipse) and ADHD subjects (hatched ellipse). (f) Chronometrics for circadian
PER2 expression in the control and ADHD groups.
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period of the activity rhythm would shorten with the
severity of the disorder. It is worth sounding a note of
caution in the interpretation of any actigraphic data,
in that it assesses the gross rhythm in motor output,
and does not delineate between endogenous circadian
processes and environmental factors, and the inter-
action between these, and thus provides limited
mechanistic insight.
Clock gene rhythms
An increasing number of laboratories are utilising
molecular circadian clocks in peripheral and easily
accessible tissues in order to gain insight into the
clock gene cycles under various conditions.19,23,24 In
the present study, we developed a novel, noninvasive
technique of sampling of oral mucosa for monitoring
of clock gene expression. The advantage of the
protocol used in this study is that it allows for self-
sampling, and so does not require laboratory-based
sampling and thus, when applied with actigraphy
allows for a more naturalistic monitoring of circadian
processes. This study is, to the best of our knowledge,
the first to examine regulation of circadian clock gene
expression in ADHD. We report a significant rhythm
of BMAL1 expression in the oral mucosa of control
subjects with significant alterations in ADHD, while
PER2 expression exhibits a significant rhythm in
controls, which is lost in ADHD. Furthermore, the
DSMIV–ADHD score is inversely correlated with the
amplitude and percentage rhythm of PER2, indicating
a relationship between the strength of clock gene
rhythmic expression and clinical ADHD ratings.
Thus, a role for dysfunction in the entrainment of
the circadian clock in ADHD may be tentatively
postulated, although it is prudent to sound a number
of notes of caution. First, we sampled one particular
peripheral circadian clock (as sampling of the master
SCN clock is obviously not possible in such studies),
and there is a paucity of information available in
relation to the regulation of the oral mucosal clock
and how it sits in the overall integrated circadian
system. Second, alteration in circadian processes in
peripheral pacemakers as noted here may not neces-
sarily reflect changes in central processes (the key
regulators of behaviour) and thus we make no claims
that the oral mucosa is a proxy for the SCN. Having
said this, it is worth noting that the characteristics of
molecular rhythms in skin fibroblasts25 and in hair
follicles23 do correlate with behavioural measures of
the subjects from whom the samples were derived, as
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Figure 2 Circadian rhythms in salivary melatonin and cortisol in control and ADHD groups. (a) Chronograms for salivary
melatonin of controls and the ADHD group. The fitted dark line represents the cosine wave of best fit with a 24h period. The
horizontal line represents the MESOR. (b) Polar plot illustrating the phase/amplitude relationship for melatonin of controls
(black ellipse) and ADHD subjects (hatched ellipse). (c) Chronometrics for salivary melatonin in the control and ADHD
groups. (d) Chronograms for the secretion of salivary cortisol in the control and the ADHD groups. The fitted dark line
represents the cosine wave of best fit with a 24h period. The horizontal line represents the MESOR. (e) Polar plot illustrating
the phase/amplitude relationship for salivary cortisol in controls (black ellipse) and ADHD subjects (hatched ellipse).
(f) Chronometrics for circadian cortisol secretion in the control and ADHD groups.
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they do in our present study (correlations between
clock gene chronometrics and actigraphic period).
Melatonin and cortisol
Our data demonstrate a robust significant rhythm of
melatonin in the healthy control group as expected,
and a loss of significant rhythmicity in adult ADHD.
This loss of rhythmicity is probably due to the
reduced amplitude of the melatonin rhythm, although
peak melatonin levels occurred at approximately the
same time as the control group. Previous studies have
reported an association of altered phasing of the
melatonin rhythm with both childhood ADHD9 and
adult ADHD.10 In these cases, an abnormal rhythm of
melatonin secretion is associated with the ADHD
where it is comorbid with sleep-onset insomnia, and a
delayed sleep phase and delayed dim-light melatonin
onset is observed. As we did not measure the dim-
light melatonin onset in the current study, a direct
comparison between our findings and those noted
above cannot be made. A simple explanation for the
dampened amplitude of melatonin secretion in
ADHD is that as melatonin secretion is inhibited by
light, an altered sleep–wake rhythm involving more
nocturnal activity, and thus increased exposure to
light, could suppress the secretion of melatonin. This
hypothesis is supported by the actigraphy data, which
demonstrate that the ADHD group is exposed to a
significantly greater amount of nocturnal light than
the control group. We report a significant rhythm of
cortisol secretion in adult ADHD, although the
rhythm of cortisol is phase delayed by B2h in
ADHD. Eveningness might be associated with a phase
delay of the cortisol rhythm,26 consistent with our
present results demonstrating that ADHD is asso-
ciated with more eveningness and a phase delay of
the cortisol rhythm. The inverse correlation between
ADHD score and the percentage of variance of the
cortisol rhythm suggests that greater robustness of the
cortisol rhythm is associated with ADHD, which is
further supported by group-wise comparisons. As the
rhythm in cortisol is known to be centrally driven via
the SCN master clock,27 the phase delay observed in
our study may further reflect a deficit in the
entrainment of the master circadian clock in adult
ADHD to appropriate environmental and social
stimuli. Seemingly normal diurnal rhythms of cortisol
secretion have been reported in adult ADHD,28,29 but
as these studies did not undertake chronometric
analysis, these findings may simply reflect the
preservation of the rhythmic cortisol levels in adult
ADHD (as reported here) but would not be able to
detect the alterations in the phasing of the rhythm
that we report. Altered neuroendocrine signalling by
melatonin or cortisol may affect the entrainment of
peripheral clocks, such as the oral mucosa.
There are a number of important caveats to consider
in the interpretation of our data set. ADHD is a very
heterogenous condition with high levels of lifetime
psychiatric comorbidities. Given that affective condi-
tions, as are often comorbid with ADHD, are also
associated with altered circadian timekeeping,30 it
Figure 3 Correlations between chronometrics and DSM-IV ADHD index scores. Significant inverse correlations between
DSM-IV ADHD index score and PER2 acrophase in controls, as well as with percentage of PER2 variance accounted for by a
24h rhythm, PER2 rhythm amplitude, cortisol percentage rhythm and actigraphic period in the ADHD group.
Adult ADHD and circadian rhythms
AL Baird et al
6
Molecular Psychiatry
will be difficult to associate any circadian alteration
directly with ADHD per se. The presence of sleep-
onset insomnia with ADHD is another factor to be
considered.10 A further complication is the unknown
effects of stimulant and non-stimulant medications
used in ADHD management on circadian parameters.
While it would be desirable to be able to control for all
of these potentially confounding factors, there is
equally an argument to be made for the assessment
of a clinically representative sample, as examined in
the current study.
Conclusions
We have demonstrated that in ADHD there are
significant disturbances not only in the rhythmic
secretion of endocrine factors that are key outputs and
regulators of the master circadian clock, but also in
circadian clock gene expression of a peripheral
oscillator and in actigraphic measures of circadian
organisation of gross behaviour. Future work should
examine chronotherapuetic approaches in ADHD and
explore the effect of ADHD medications upon the
circadian clock. Further research into modulation of
circadian deficits in ADHD may prove beneficial in
understanding the underlying causes of the sympto-
mology and may serve to aid in appropriate and
efficacious treatment of the disorder.
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